微生物组与宿主相互作用在慢性阻塞性肺部疾病急性恶化病原体中的作用
Yao Li1, Xiaoyan Mao2, Pengfei Shi1
1Department of Respiratory and Critical Care Medicine, Huaian Clinical College of Xuzhou Medical University, Huaian, China.
Frontiers in cellular and infection microbiology
|August 2, 2024
概括
气道微生物组的改变,包括在恶化期间增加的Rothia mucilaginosa,可能会通过天生的免疫路径驱动慢性阻塞性肺病 (AECOPD) 的急性恶化. 这项研究突出了AECOPD的潜在治疗目标.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种渐进的肺病.
- 慢性慢性肺炎的急性恶化 (AECOPD) 显著恶化患者的结果,增加死亡率.
- 呼吸道微生物组在AECOPD病原体中的作用尚未完全理解.
研究的目的:
- 调查气道微生物群对AECOPD背后的机制的贡献.
- 确定与AECOPD相关的特定微生物和宿主基因表达模式.
主要方法:
- 从31名AECOPD患者和26名稳定的COPD患者中采集了唾液样本.
- 在唾液样本上进行了元基因组和RNA测序.
- 使用定量实时PCR (qPCR) 验证了宿主基因表达.
主要成果:
- 在AECOPD组中观察到*Rothia mucilaginosa*的表达更高 (p=0.015).
- 差异表达基因 (DEGs) 在包括I型干扰素,细胞质DNA传感,Toll类受体和TNF信号传递在内的途径中得到丰富.
- 在AECOPD组中,qPCR证实了*OASL*和*IL6*的表达增加.
结论:
- 肺部细菌失生可能有助于AECOPD的发病.
- 天生的免疫系统途径,如I型干扰素和Toll-like受体信号传递,都与AECOPD有关.
- 这些发现表明AECOPD管理的潜在治疗目标.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Pathogenesis and Clinical Features
251
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
251


